Intal compound for asthma
- 10 May 1968
- journal article
- research article
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 6 (10) , 37-38
- https://doi.org/10.1136/dtb.6.10.37
Abstract
Intal compound is a new preparation for asthma marketed by Fisons Pharmaceuticals. Before it was launched the parent company told a newspaper ‘we believe it to be 100% effective’,1but this statement was probably aimed at investors rather than doctors or patients. The preparation is a mixture of disodium cromoglycate 20 mg, isoprenaline sulphate 0.1 mg and lactose and is dispensed as a fine powder in a capsule for release from a special inhaler.Keywords
This publication has 0 references indexed in Scilit: